Current Problems in Cardiology
Volume 35, Issue 6 , Pages 284-306 , June 2010

Statins for Calcific Aortic Valve Stenosis: Into Oblivion After SALTIRE and SEAS? An Extensive Review from Bench to Bedside

References 

  1. Lindroos M, Kuppari M, Heikkilä J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21(5):1220–1225
  2. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230–268
  3. Aronow WS, Ahn C, Kronzon I, et al. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88(6):693–695
  4. Novaro GM, Tiong I, Pearce GL, et al. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic valve stenosis. Circulation. 2001;104:2205–2209
  5. Bellamy MF, Pellikka PA, Klarich KW, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol. 2002;40:1723–1730
  6. Shavelle DM, Takasu J, Budoff MJ, et al. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet. 2002;359(9312):1125–1126
  7. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291–1295
  8. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49:554–561
  9. Pohle K, Mäffert R, Ropers D, et al. Progression of aortic valve calcification (Association with coronary atherosclerosis and cardiovascular risk factors). Circulation. 2001;104:1927–1932
  10. Rossebø AB, Pedersen T, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359:1343–1356
  11. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389–2397
  12. Lindroos M, Kupari M, Valvanne J, et al. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J. 1994;15(7):865–870
  13. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease (Cardiovascular health study). J Am Coll Cardiol. 1997;29:630–634
  14. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J. 2003;24:1231–1243
  15. Olsson M, Dalsgaard CJ, Haegerstrand A, et al. Accumulation of T-lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol. 1994;23(5):1162–1170
  16. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of degenerative valvular aortic stenosis (Histological and immunohistochemical studies). Circulation. 1994;90:844–853
  17. O'Brien KD, Reichenbach DD, Marcinova SM, et al. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of degenerative valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996;16:523–532
  18. Rajamannan NM, Subramaniam M, Springett M, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2660–2665
  19. Simmons CA, Grant GR, Manduchi E, et al. Spatial heterogeneity of endothelial phenotypes correlates with site-specific vulnerability to calcification in normal porcine aortic valves. Circ Res. 2005;96:792–799
  20. Vasile E, Antohe F. An ultrastructural study of beta very low density lipoprotein uptake and transport by valvular endothelium of hyperlipidemic rabbits. J Submicrosc Cytol Pathol. 1991;23:279–287
  21. Nievelstein-Post P, Mottino G, Fogelman A, et al. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler Thromb. 1994;14:1151–1161
  22. Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis. 2001;10:371–374
  23. Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol. 2003;41:1211–1217
  24. Cimini M, Boughner DR, Ronald JA, et al. Development of aortic valve stenosis in a rabbit model of atherosclerosis: an immunohistochemical and histological study. J Heart Valve Dis. 2005;14:365–375
  25. Zeng Z, Nievelstein-Post P, Yin Y, et al. Macromolecular transport in heart valves III: experiment and theory for the size distribution of extracellular liposomes in hyperlipidemic rabbits. Am J Physiol Heart Circ Physiol. 2007;292:H2687–H2697
  26. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix gla protein. Nature. 1997;386:78–81
  27. Galvin KM, Donovan MJ, Lynch CA, et al. A role for SmadVI in development and homeostasis of the cardiovascular system. Nat Genet. 2000;24:171–174
  28. Lee TC, Zhao YD, Courtman DW, et al. Abnormal aortic development in mice lacking endothelial nitric oxide synthase. Circulation. 2000;101:2345–2348
  29. Tanaka K, Sata M, Fukuda D, et al. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J Am Coll Cardiol. 2005;46:134–141
  30. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH 1 cause aortic valve disease. Nature. 2005;437:270–274
  31. Drolet MC, Roussel E, Deshaies Y, et al. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. J Am Coll Cardiol. 2006;47:850–855
  32. Weiss RM, Ohashi M, Miller JD, et al. Dl. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation. 2006;114:2065–2069
  33. Aikawa E, Nahrendorf M, Sosnovik D, et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007;115:377–386
  34. Davignon J. Beneficial cardiovascular pleitropic effects of statins. Circulation. 2004;109(suppl III):III-39–III-43
  35. Soini Y, Salo T, Satta J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum Pathol. 2003;34(8):756–763
  36. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation. 2003;107:2181–2184
  37. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated regurgitation. Circulation. 2005;111:920–925
  38. Thubrikar MJ, Aouad J, Nolan SP. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. Am J Cardiol. 1986;58(3):304–308
  39. Nicosia MA, Cochran RP, Reichenbach DR, et al. A coupled fluid-structure finite-element model of the aortic valve and root. J Heart Valve Dis. 2003;12:781–789
  40. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(suppl lIII):III-27–III-32
  41. Tiwari RL, Singh V, Barthwal MK. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med Res Rev. 2008;28(4):483–544
  42. Robicsek F, Thubrikar MJ, Fokin AA. Cause of degenerative disease of the trileaflet valve: review of the subject and presentation of a new theory. Ann Thorac Surg. 2002;73:1346–1354
  43. Singh R, Strom JA, Ondrovic L, et al. Age-related changes in the aortic valve affect leaflet stress distributions: implications for aortic valve degeneration. J Heart Valve Dis. 2008;17(3):290–298
  44. Sacks MS, Yoganathan AP. Heart valve function: a biomechanical perspective. Philos Trans R Soc Lond. 2007;362:1369–1391
  45. Balachandran K, Sucosky P, Jo H, et al. Elevated cyclic stretch alters matrix remodelling in aortic valve cusps: implications for degenerative aortic valve disease. Am J Physiol Heart Circ Physiol. 2009;296:H756–H764
  46. Merryman WD, Lukoff HD, Long RA, et al. Synergistic effects of cyclic tension and transforming growth factor -β1 on the aortic valve myofibroblast. Cardiovasc Pathol. 2007;16:268–276
  47. Sucosky P, Balachandran K, Elhammaly A, et al. Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGFβ1-dependent pathway. Arterioscler Thromb Vasc Biol. 2009;29:254–260
  48. El-Hamamsy I, Balachandran K, Yacoub MH, et al. Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol. 2009;53:1448–1455
  49. Butcher JT, Penrod AM, Garcia AJ, et al. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol. 2004;24:1429–1434
  50. Butcher JT, Tressel S, Johnson T, et al. Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences (Influence of shear stress). Arterioscler Thromb Vasc Biol. 2006;26:69–77
  51. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol. 2007;171:1407–1418
  52. Paranya G, Vineberg S, Dvorin E, et al. Aortic valve endothelial cells undergo transforming-growth-factor-β-mediated and non-transforming-growth-factor-β-mediated transdifferentiation in vitro. Am J Pathol. 2001;159:1335–1343
  53. Paruchuri S, Yang JH, Aikawa E, et al. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming-growth-factor-β2. Circ Res. 2006;99:861–869
  54. Yip CYY, Chen JH, Zhao R, et al. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol. 2009;29:936
  55. Monzack EL, Gu X, Masters KS. Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment. Arterioscler Thromb Vasc Biol. 2009;29:246–253
  56. Wu B, Elmariah S, Kaplan FS, et al. Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts (Implications for end-stage valvular heart disease). Arterioscler Thromb Vasc Biol. 2005;25:592–597
  57. Anger T, El-Chafchak J, Habib A, et al. Statins stimulate RGS-regulated ERK ½ activation in human calcified and stenotic aortic valves. Exp Mol Pathol. 2008;85:101–111
  58. Edep ME, Shirani J, Wolf P, et al. Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol. 2000;9:281–286
  59. Fondard O, Detaint D, Iung B, et al. Extracellular matrix remodeling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J. 2005;26:1333–1341
  60. Satta J, Oiva J, Salo T, et al. Evidence for an altered balance between matrix-metalloproteinase-9 and its inhibitors in calcific aortic stenosis. Ann Thorac Surg. 2003;76:681–688
  61. Helske S, Syvaranta S, Lindstedt KA, et al. Increased expression of elasolytic cathepsins S, K, V and their inhibitor cystatin C in stenotic aortic valves. Arterioscler Thromb Vasc Biol. 2006;26:1791–1798
  62. Helske S, Syvaranta S, Kupari M, et al. Possible role for mast cell-derived cathepsin G in the adverse remodeling of aortic valves. Eur Heart J. 2006;27:1495–1504
  63. Kaden JJ, Dempfle CE, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol. 2005;14:80–87
  64. Mohty D, Pibarot P, Després JP, et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol. 2008;28:187–193
  65. Warren BA, Yong JL. Calcification of the aortic valve: its progression and grading. Pathology. 1997;29(4):360–368
  66. Chen K, Thomas SR, Keaney JF, et al. Oxidation: ROS in vascular signal transduction. Free Radic Biol Med. 2003;35:117–132
  67. Miller JD, Chu Y, Brooks RM, et al. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol. 2008;52:843–850
  68. Liberman M, Bassi E, Martinatti MK, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol. 2008;28:463–470
  69. Towler DA. Oxidation, inflammation, and aortic valve calcification. J Am Coll Cardiol. 2008;52:851–854
  70. Maher ER, Young G, Smyth-Walsh B, et al. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet. 1987;2(8564):875–877
  71. Ortlepp JR, Pillich M, Schmitz F, et al. Lower serum calcium levels are associated with greater calcium hydroxyapatite deposition in native aortic valves of male patients with severe calcific aortic stenosis. J Heart Valve Dis. 2006;15(4):502–508
  72. Linhartova K, Veselka J, Sterbakova G, et al. Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis. Circ J. 2008;72:245–250
  73. O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation. 1995;92:2163–2168
  74. Mohler ER, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522–1528
  75. Caira FC, Stock SR, Gleason TG, et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein-5 receptor-mediated bone formation. J Am Coll Cardiol. 2006;47:1707–1712
  76. Kaden JJ, Bickelhaupt S, Grobholz R, et al. Receptor activator of nuclear factor kB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol. 2004;36:57–66
  77. Steinmetz M, Skowasch D, Wernert N, et al. Differential profile of the OPG/RANKL/RANK system in degenerative aortic native and bioprosthetic valves. J Heart Valve Dis. 2008;17(2):187–193
  78. Satta J, Melkko J, Pöllänen R, et al. Progression of human aortic valve stenosis is associated with tenascin-C expression. J Am Coll Cardiol. 2002;39:96–101
  79. Meng X, Ao L, Song Y, et al. Expression of functional toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis. Am J Physiol Cell Physiol. 2008;294:C29–C35
  80. Yang X, Fullerton DA, Su X, et al. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of toll-like receptors 2 and 4 and enhanced expression of bone morphogenic protein 2. J Am Coll Cardiol. 2009;53(6):491–500
  81. Helske S, Lindstedt KA, Laine M, et al. Induction of local angiotensin II producing systems in stenotic aortic valves. J Am Coll Cardiol. 2004;44:1859–1866
  82. O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation. 2002;106:2224–2230
  83. Holvoet P, De Keyzer D, Jacobs DR, et al. And the metabolic syndrome. Futures Lipidol. 2008;3(6):637–649
  84. Mazzone A, Epistolato MC, De Caterina R, et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein- 60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J Am Coll Cardiol. 2004;43:1670–1676
  85. Ortlepp JR, Hoffmann R, Ohme F, et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001;85:635–638
  86. Garg V, Muth AN, Ransom JF, et al. Mutations in Notch 1 cause aortic valve disease. Nature. 2005;437:270–274
  87. Nordström P, Glader CA, Dahlen G, et al. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med. 2003;254:140–146
  88. Novaro GM, Sachar R, Pearce GL, et al. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation. 2003;108:1804–1808
  89. Avakian SD, Annicchino-Bizzacchi JM, Grinberg M, et al. Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis. Clin Genet. 2001;60:381–384
  90. Ortlepp JR, Pillich M, Mevissen V, et al. ApoE alleles are not associated with calcific aortic stenosis. Heart. 2006;92:1463–1466
  91. Ortlepp JR, Schmitz F, Mevissen V, et al. The amount of calcium-deficient hexagonal hydroxyapatite in aortic valves is influenced by gender and associated with genetic polymorphisms in patients with severe calcific aortic stenosis. Eur Heart J. 2004;25:514–522
  92. Golubnitschaja O, Yeghiazaryan K, Skowasch D, et al. P21WAF1/CIP1 and 14-3-3 sigma gene expression in degenerated aortic valves: a link between cell cycle checkpoints and calcification. Amino Acids. 2006;31:309–316
  93. Kuusisto J, Räsänen K, Särkioja T, et al. Atherosclerosis-like lesions of the aortic valve are common in adults of all ages: a necropsy study. Heart. 2005;91:576–582
  94. Probst V, Le Scouarnec S, Legendre A, et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation. 2006;113:856–860
  95. Roger VL, Tajik AJ, Bailey KR, et al. Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. Am Heart J. 1990;119:331–338
  96. Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis (Natural history and risk stratification by echocardiography). Eur Heart J. 2004;25:199–205
  97. Briand M, Lemieux I, Dumesnil JG, et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol. 2006;47:2229–2236
  98. Antonini-Canterin F, Hirsu M, Popescu BA, et al. Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. Am J Cardiol. 2008;102:738–742

 The authors have no conflicts of interests to disclose.

 Hadewich Hermans, MD, is supported by the Flanders Research Foundation (FWO) to prepare a PhD thesis.

PII: S0146-2806(10)00026-5

doi: 10.1016/j.cpcardiol.2010.02.002

Current Problems in Cardiology
Volume 35, Issue 6 , Pages 284-306 , June 2010

Article Tools

* Image Usage & Resolution